Xun Zhu
Directeur/Bestuurslid bij SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.
Vermogen: 750 926 $ op 30-04-2024
Actieve functies van Xun Zhu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Directeur/Bestuurslid | 20-02-2014 | - |
Independent Dir/Board Member | 20-02-2014 | - | |
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Directeur/Bestuurslid | 24-03-2018 | - |
Independent Dir/Board Member | 24-03-2018 | - | |
LANSEN PHARMACEUTICAL HOLDINGS LIMITED | Directeur/Bestuurslid | 23-09-2022 | - |
Independent Dir/Board Member | 23-09-2022 | - | |
HIGHTIDE THERAPEUTICS, INC. | Directeur/Bestuurslid | 30-11-2020 | - |
Cathay International Pharmaceutical Ltd. | Directeur/Bestuurslid | 01-08-2011 | - |
China Medicinal Biotech Association | Corporate Officer/Principal | - | - |
Norman Bethune Medical University | Corporate Officer/Principal | 01-01-1995 | - |
National Natural Science Foundation of China | Corporate Officer/Principal | - | - |
Loopbaan van Xun Zhu
Eerdere bekende functies van Xun Zhu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Jilin University | Corporate Officer/Principal | 01-08-1994 | 01-06-2018 |
░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | - | - |
Opleiding van Xun Zhu
Norman Bethune Medical University | Doctorate Degree |
Statistieken
Internationaal
China | 8 |
Verenigde Staten | 2 |
Kaaimaneilanden | 2 |
Operationeel
Director/Board Member | 6 |
Independent Dir/Board Member | 4 |
Corporate Officer/Principal | 4 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Government | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. | Health Technology |
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Health Technology |
LANSEN PHARMACEUTICAL HOLDINGS LIMITED | Health Technology |
HIGHTIDE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Cathay International Pharmaceutical Ltd. | |
China Medicinal Biotech Association | |
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |
National Natural Science Foundation of China | Government |